GB12-09, a bispecific antibody targeting IL4Rα and IL31Rα for atopic dermatitis therapy Statement of Significance: This research highlighted a novel approach to atopic dermatitis therapy by employing bispecific antibody targeting IL4Rα and IL3

Antibody Therapeutics(IF=4.5, Oxford University Press)
🎯🎯GB12-09, a bispecific antibody targeting IL4Rα and IL31Rα for atopic dermatitis therapy
academic.oup.com/abt/article/...
#IL4Ra #IL31Ra #AtopicDermatitis #Antibody